Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Orbita has introduce a cloud-based network to improve the connectivity of home healthcare devices, allowing patients to create, manage and deliver digital home healthcare information to hospitals and physicians.
A new hemostatic clipping device will soon enter the market as a technology designed to give physicians more control when placing clips on a patient’s gastrointestinal tract.
Validic and Sutter Health have partnered together to conduct a pilot project to see how patient-generated health data (PGHD) can be shown to improve patient care and outcomes.
The four-hospital Susquehanna Health system is officially a part of the University of Pittsburgh Medical Center (UPMC), with the deal including $500 million in renovations and upgrades at the newly acquired facilities.
Testing for cancer that would otherwise need to be done in laboratory can now be performed through smartphones thanks to work from researchers at Washington State University (WSU).
Lazarex Cancer Foundation and Oncology Research Information Exchange Network (ORIEN) have partnered to improve access to clinical trials by cancer patients via the IMPACT program (Improving Patient Access to Cancer Clinical Trials).
The Lupus Research Alliance has launched the Lupus Clinical Investigators Network (LuCIN) to improve the identify and monitor new lupus treatments.
Researchers believe data from fitness trackers (including total step counts) can also tell how well patients will recover from major abdominal operations. These wearables provide an easier way for surgeons to monitor patients following discharge, which can offer greater insight into postoperative functional recovery.
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
